<level>
  <type>section</type>
  <num>29-6264</num>
  <heading>THERAPEUTIC USE OF PSYCHOTROPIC MEDICATIONS (ยง 29-6264)</heading>
  <level>
    <num>6264.1.</num>
    <text>If psychotropic medication is prescribed, the facility shall cooperate with the contracting entity and, where applicable, the CSSD to obtain a written report from the prescribing physician detailing:</text>
    <level>
      <num>(a)</num>
      <text>The type of medication;</text>
    </level>
    <level>
      <num>(b)</num>
      <text>The dosage;</text>
    </level>
    <level>
      <num>(c)</num>
      <text>The necessity for the medication;</text>
    </level>
    <level>
      <num>(d)</num>
      <text>The resident&amp;#8217;s other medications and the effect of their interaction;</text>
    </level>
    <level>
      <num>(e)</num>
      <text>The staff monitoring requirements, if any;</text>
    </level>
    <level>
      <num>(f)</num>
      <text>Potential side effects;</text>
    </level>
    <level>
      <num>(g)</num>
      <text>The next scheduled clinical meeting; and</text>
    </level>
    <level>
      <num>(h)</num>
      <text>A current therapeutic treatment plan or behavioral management plan.</text>
    </level>
  </level>
  <level>
    <num>6264.2.</num>
    <text>The facility shall cooperate with the contracting entity and, where applicable, the CSSD to obtain written consent from the resident&amp;#8217;s parent(s) or guardian(s), or court order, before administering psychotropic medications.</text>
  </level>
  <level>
    <num>6264.3.</num>
    <text>The facility shall document the prescription and administration of medication, and notify attending physicians of, and record, significant changes in a resident&amp;#8217;s behavior or health.</text>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>SOURCE</heading>
      <text>Final Rulemaking published at 48 DCR 8675, 8729 (September 21, 2001).</text>
    </level>
  </level>
</level>